A Comprehensive Review of Topical Odor-Controlling Treatment Options for Chronic Wounds.

Alma Akhmetova, Timur Saliev, Iain U Allan, Matthew J Illsley, Talgat Nurgozhin, Sergey Mikhalovsky

Journal: Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society 2017;43(6):598-609

PMID: 27684356

Abstract

The process of wound healing is often accompanied by bacterial infection or critical colonization, resulting in protracted inflammation, delayed reepithelization, and production of pungent odors. The malodor produced by these wounds may lower health-related quality of life and produce psychological discomfort and social isolation. Current management focuses on reducing bacterial activity within the wound site and absorbing malodorous gases. For example, charcoal-based materials have been incorporated into dressing for direct adsorption of the responsible gases. In addition, multiple topical agents, including silver, iodine, honey, sugar, and essential oils, have been suggested for incorporation into dressings in an attempt to control the underlying bacterial infection. This review describes options for controlling malodor in chronic wounds, the benefits and drawbacks of each topical agent, and their mode of action. We also discuss the use of subjective odor evaluation techniques to assess the efficacy of odor-controlling therapies. The perspectives of employing novel biomaterials and technologies for wound odor management are also presented.

Address: Alma Akhmetova, BSc, Laboratory of Experimental and Clinical Pharmacology and Pharmacy, National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan. Timur Saliev, MD, PhD, Laboratory of Translational Medicine and Life Sciences Technologies, National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan. Iain U. Allan, PhD, School of Biomaterials and Biomolecular Sciences, University of Brighton, Brighton, United Kingdom. Matthew J. Illsley, PhD, School of Biomaterials and Biomolecular Sciences, University of Brighton, Brighton, United Kingdom. Talgat Nurgozhin, MD, PhD, Laboratory of Experimental and Clinical Pharmacology and Pharmacy, National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan. Sergey Mikhalovsky, PhD, School of Biomaterials and Biomolecular Sciences, University of Brighton, Brighton, United Kingdom; and School of Engineering, Nazarbayev University, Astana, Kazakhstan.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.